Brief: Chong Kun Dang Pharmaceutical Q1 Operating Profit Falls 13 Percent Y/Y
26/04/2019 08:19
April 26 (Reuters) - Chong Kun Dang Pharmaceutical Corp
185750.KS :
* SAYS Q1 OPERATING PROFIT FALLS 13 PERCENT Y/Y TO 16.7
BILLION
WON ($14.40 million)
Source text for Eikon: https://bit.ly/2UU7Noi
Further company coverage: 185750.KS
($1 = 1,160.0900 won)
((Reuters Messaging:
hayoung.choi.thomsonreuters.com@reuters.net))
Recent news on Chong Kun Dang Pharmaceutical
See all newsBrief: Chong Kun Dang Pharmaceutical Corp To Invest 392.5 Billion Won In Research Centre And Other Facility
Brief: Chong Kun Dang Pharmaceutical Q1 Operating Profit 17.6 Billion Won, Up 37% From Year Earlier
Brief: Chong Kun Dang Pharmaceutical Q3 Operating Profit 20.5 Billion Won, Down 19% From Year Earlier
Brief: Chong Kun Dang Pharmaceutical To Divest 61 Billion Won Worth Of Own Shares
Brief: Chong Kun Dang Pharmaceutical Q1 Operating Profit 12.8 Billion Won, Down 52% From Year Earlier